2008
DOI: 10.1016/j.transproceed.2008.03.113
|View full text |Cite
|
Sign up to set email alerts
|

Human Adipose Tissue-Derived Mesenchymal Stem Cells Combined With Hematopoietic Stem Cell Transplantation Synthesize Insulin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
78
0
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 100 publications
(79 citation statements)
references
References 7 publications
0
78
0
1
Order By: Relevance
“…A cohort of diabetic patients in whom insulin secreting MSC were transplanted had no side/adverse effects or malignancy noted so far over a follow-up of 2.5 years (Trivedi et al 2008).…”
Section: Discussionmentioning
confidence: 94%
“…A cohort of diabetic patients in whom insulin secreting MSC were transplanted had no side/adverse effects or malignancy noted so far over a follow-up of 2.5 years (Trivedi et al 2008).…”
Section: Discussionmentioning
confidence: 94%
“…Reprogramming memory may suggest incomplete reprogramming of iPSCs, while if pPiPSCs could retain the properties of original cells that could be beneficial in clinical practice or basic research, they may have useful applications. ADSCs possess the capacity of multipotency (Oswald et al 2004, Lindroos et al 2011, high activity of secretion (Spaggiari et al 2009, Nguyen et al 2010, homing (Lamfers et al 2009), and immune modification (Yanez et al 2006), and have been widely used in cell replacement therapy (CRT) and clinical research (Trivedi et al 2008, Ichim et al 2010. We questioned as to whether pPiPSCs retained these favorable characteristics after reprogramming.…”
Section: Discussionmentioning
confidence: 99%
“…Owing to their low immunogenicity and immunosuppression in vivo and in vitro, ADSCs can be applied in healing immunodeficiency diseases such as graft-vs-host diseases (Yanez et al 2006), diabetes (Trivedi et al 2008), and rheumatoid arthritis (Ichim et al 2010). When antigens enter the body, their major histocompatibility complex (MHC) is the first to be recognized and provides the first signal of the immune response.…”
Section: Discussionmentioning
confidence: 99%
“…In vitro functionality of these cells was also confirmed by insulin production and release in a glucose-responsive manner. [4][5][6] We decided to infuse the cells in portal circulation since liver is the most tolerogenic organ 7 . LADA is believed to be an auto-immune disorder and once the cells are infused in to thymus, it helps in preventing the rejection of these cells by inducing central tolerance 8 .…”
Section: Discussionmentioning
confidence: 99%